BNP
Dead / Cancelled — Cancelled — Section 8 (as of 13 May 2015)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78681251
- Registration number
- 3254910
- Mark type
- Stylized text
- Filed
- 29 Jul 2005
- Published for opposition
- 10 Apr 2007
- Registered
- 26 Jun 2007
- Attorney of record
- Mark Turner
Goods and services
- Class 001 — Chemicals: Biotechnological product, namely, viral DNA vector, for delivery of genes and other materials, namely RNAi and transcriptional targeting promoters, to a biological cell
Owner
- Asklepios BioPharmaceutical, Inc., Chapel Hill, NC, US
- Asklepios BioPharmaceutical, Inc., Chapel Hill, NC, US
- Asklepios BioPharmaceutical, Inc., Chapel Hill, NC, US
Prosecution history
- 13 May 2015 — CANCELLED SEC. 8 (6-YR)
- 06 Jan 2009 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 06 Jan 2009 — ASSIGNED TO PARALEGAL
- 06 Jan 2009 — ASSIGNED TO PARALEGAL
- 16 Dec 2008 — TEAS SECTION 7 REQUEST RECEIVED
- 20 Oct 2008 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Oct 2008 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Apr 2008 — POST REGISTRATION ACTION MAILED - SEC. 7
- 28 Mar 2008 — RESPONSE RECEIVED TO POST REG. ACTION
- 28 Mar 2008 — PAPER RECEIVED
- 14 Feb 2008 — TEAS SECTION 7 REQUEST RECEIVED
- 26 Jun 2007 — REGISTERED-PRINCIPAL REGISTER
- 10 Apr 2007 — PUBLISHED FOR OPPOSITION
- 21 Mar 2007 — NOTICE OF PUBLICATION
- 29 Sept 2006 — ASSIGNED TO LIE